Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Probiotics

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...

Carbohydrate Absorption

Carbohydrate Absorption

Carbohydrates are essential macronutrients that serve as the body's primary energy source. Their digestion begins in the mouth, where salivary amylase partially breaks down complex carbohydrates such as starch into smaller oligosaccharides. This mechanical and enzymatic activity prepares carbohydrates for further processing in the gastrointestinal tract.
After being swallowed, the partially digested carbohydrates mix with gastric secretions in the stomach. However, the acidic environment...

Biosynthesis of Polysaccharides

Biosynthesis of Polysaccharides

Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Influence of 2'-fucosyllactose and galacto-oligosaccharides on the growth and adhesion of <i>Streptococcus mutans</i>.

The British journal of nutrition·2020

Same author

Considerations for the design and conduct of human gut microbiota intervention studies relating to foods.

European journal of nutrition·2020

Same author

Safety assessment of the biotechnologically produced human-identical milk oligosaccharide 3-Fucosyllactose (3-FL).

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2019

Same author

The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial.

Beneficial microbes·2019

Same author

Simulating colonic survival of probiotics in single-strain products compared to multi-strain products.

Microbial ecology in health and disease·2017

Same author

Effect of probiotic supplementation on total lactobacilli, bifidobacteria and short chain fatty acids in 2-5-year-old children.

Microbial ecology in health and disease·2017

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems

Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems

Published on: August 23, 2019

Panose, a new prebiotic candidate.

H Mäkeläinen¹, O Hasselwander, N Rautonen

¹Health and Nutrition, Danisco Finland, Kantvik, Finland. henna.makelainen@danisco.com

Letters in Applied Microbiology

|October 31, 2009

Summary

This summary is machine-generated.

Panose exhibits prebiotic potential by selectively promoting beneficial gut bacteria like Bifidobacterium. This fermentation also increased beneficial short-chain fatty acids and reduced protein fermentation markers in vitro.

Related Experiment Videos

Last Updated: Jun 19, 2026

Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems

Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems

Published on: August 23, 2019

Area of Science:

Microbiology
Gastroenterology
Nutritional Science

Background:

Understanding the prebiotic potential of novel oligosaccharides is crucial for gut health.
Sophorose and panose are novel candidates for prebiotic evaluation.
In vitro methods allow for controlled assessment of microbial interactions with substrates.

Purpose of the Study:

To investigate the prebiotic potential of sophorose and panose using in vitro methods.
To assess the fermentation of panose by a mixed human fecal microbiota in a simulated colon environment.

Main Methods:

Pure cultures of microbial strains were used to assess substrate fermentation.
A simulated colon model with mixed human fecal culture was employed for panose analysis.
Quantitative PCR, flow cytometry, and chromatographic methods were utilized to quantify microbial populations and metabolites.

Main Results:

Both sophorose and panose were fermented by a limited number of beneficial bacterial strains in pure culture.
Panose significantly increased Bifidobacterium and Bifidobacterium lactis populations while decreasing the Bacteroides group in a simulated colon.
Panose fermentation led to increased production of butyrate and acetate and decreased markers of protein fermentation.

Conclusions:

Panose demonstrates significant bifidogenic activity in vitro.
The findings suggest panose has prebiotic potential, warranting further in vitro and in vivo investigation.
This study provides initial data on panose fermentation by endogenous microbiota, enhancing understanding of oligosaccharide selectivity by intestinal microbes.